← Back to Search

SMART Program for Inflammatory Bowel Disease

N/A

Recruiting

Led By Shayla Schoenoff, PA-C, MS

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, approximately 20 weeks

Awards & highlights

Study Summary

This trial looks at how a SMART Program can improve the quality of life & reduce healthcare use for those with IBD.

Who is the study for?

This trial is for individuals with inflammatory bowel disease (IBD) who feel stress affects their symptoms. Participants must have internet access and a device like a smartphone, tablet, or computer. They can't join if they've used corticosteroids in the past 3 months or use illicit substances including medical marijuana.Check my eligibility

What is being tested?

The study examines how a Stress Management and Resilience Training (SMART) Program might improve life quality and affect healthcare needs for those with IBD. It's about learning to handle stress better to see if it helps manage IBD symptoms.See study design

What are the potential side effects?

Since this program focuses on managing stress rather than medication, there are no direct side effects like you'd expect from drugs. However, participants may experience varying levels of emotional discomfort when addressing personal stressors.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, approximately 20 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, approximately 20 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, approximately 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Inflammatory Bowel Disease (IBD) Quality of Life (QOL)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Stress management and resilience trainingExperimental Treatment1 Intervention

Subjects will receive a 1.5 hour one-on-one stress management and resilience consult by a certified SMART trainer followed by 16 week self-guided on-line training.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Stress Management and Resilience Training Program

2018

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,213 Previous Clinical Trials

3,766,981 Total Patients Enrolled

Shayla Schoenoff, PA-C, MSPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this experiment accessible to potential participants?

"Confirmed. Clinicaltrials.gov attests to the fact that this medical trial, first introduced on September 1st 2023, is still actively seeking participants and was recently updated on the 6th of September 2023."

Answered by AI

What is the capacity for participants in this trial?

"Affirmative. According to clinicaltrials.gov, this medical trial is currently recruiting participants and was initially published on September 1st 2023. The study requires 30 patients from one site for completion and the data has been modified as recently as August 6th 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases

Shayla A. Schoenoff 2023. "SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06002074.

All > Inflammatory Bowel Disease